Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Gosia Ciepielewska"'
Autor:
Antonio Flavio Lima, J. Bradford Rice, Thomas A. Albini, Laura Bartels-Peculis, Gosia Ciepielewska, Michaela Johnson, Alan G. White, Winnie W. Nelson, Julie Reiff
Publikováno v:
Clinical Therapeutics. 41:2331-2342
Noninfectious inflammatory eye diseases (NIIEDs), such as uveitis, is a general term used to describe a complex mix of acute, chronic, allergic, and inflammatory disorders. Prior literature has established that, in addition to severe clinical burden,
Autor:
J. Bradford Rice, Laura Bartels-Peculis, Winnie W. Nelson, Julie Reiff, Alan G. White, Thomas A. Albini, Antonio Flavio Lima, Michaela Johnson, Gosia Ciepielewska
Publikováno v:
Ocular Immunology and Inflammation. 28:164-174
Purpose: To assess the economic burden of non-infectious inflammatory eyedisease (NIIED) in a commercially-insured population in the United StatesMethods: Adult patients with a NIIED diagnosis betwe...
Autor:
Gosia Ciepielewska, Alan G. White, J. Bradford Rice, Winnie W. Nelson, Laura Bartels-Peculis, Yimin Qin, Michaela Johnson, Aneesha Wagh
Publikováno v:
Current Medical Research and Opinion. 34:1519-1527
This retrospective study assessed the incidence and timing of adverse events (AEs) among patients prescribed varying dose levels of corticosteroids in the US.Patients with selected autoimmune or inflammatory disease diagnoses between 2006 and 2015 we
Autor:
Gosia Ciepielewska, J. Bradford Rice, Michaela Johnson, Laura Bartels-Peculis, Aneesha Wagh, Winnie W. Nelson, Yimin Qin, Alan G. White
Publikováno v:
Journal of Medical Economics. 21:846-852
To quantify healthcare resource use (HCRU) and costs associated with varying levels of corticosteroid exposure.Patients with a diagnosis of selected autoimmune and inflammatory diseases between 1 January 2006 and 30 September 2015 ("study period") we
Autor:
Antonio Flavio Lima, Gosia Ciepielewska, Susan Carroll, Winnie W. Nelson, Jack R. Gallagher, John Kranyak, Kylee Heap, Barima Opong-Owusu
Publikováno v:
Journal of Ocular Pharmacology and Therapeutics
Introduction: Repository corticotropin injection (RCI) has immune-modulatory and anti-inflammatory effects and is approved for multiple indications, including severe and acute chronic allergic and inflammatory processes involving the eye and adnexa.